Skip to main content
. 2025 Sep 1;18(9):1311. doi: 10.3390/ph18091311
ACE Angiotensin-converting enzyme
AE Adverse event
ARB Angiotensin receptor blocker
aROR Adjusted reporting odds ratio
BB Beta-adrenergic receptor blocker
CI Confidence interval
cROR Crude reporting odds ratio
CV Cardiovascular
CYP Cytochrome P450 enzyme
DHP-CCB Dihydropyridine calcium channel blocker
DOAC Direct oral anticoagulant
EBGM Empirical Bayesian geometric mean
FAERS Food and Drug Administration Adverse Event Reporting System
GERD Gastroesophageal reflux disease
GI Gastrointestinal
H2RA Histamine 2 receptor antagonist
IC Information component
ICSR Individual case safety report
LCI Lower limit of 95% confidence interval
LLT Lowest-level term
NDHP-CCB Non-dihydropyridine calcium channel blocker
NSAID Non-steroidal anti-inflammatory drug
OAC Oral anticoagulant
PCAB Potassium-competitive acid blocker
P-gp P-glycoprotein
PPI Proton pump inhibitor
PRR Proportional reporting ratio
ROR Reporting odds ratio